Elanco Animal Health (ELAN) Tops Q1 EPS by 1c; Guides Q2 Lower
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/24/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
Elanco Animal Health Reports First Quarter 2022 Results
May 9, 2022 6:30 AM EDTFirst Quarter 2022 Financial Results Revenue of $1,225 million Reported Net Income of $48 million, Adjusted Net Income of $177 million Adjusted EBITDA of $339 million or 27.7% of Revenue Reported EPS of $0.10, Adjusted EPS of $0.36 Updating full year 2022 revenue guidance to be $4,700 to $4,755 million, due to the negative impact of foreign exchange rates; constant currency revenue growth guidance remains unchanged. Increasing guidance for full year 2022 diluted EPS to $0.02 to $0.09 on a reported basis and updating... More



